These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Models for describing relations among the various statin drugs, low-density lipoprotein cholesterol lowering, pleiotropic effects, and cardiovascular risk. Robinson JG Am J Cardiol; 2008 Apr; 101(7):1009-15. PubMed ID: 18359323 [TBL] [Abstract][Full Text] [Related]
3. Pleiotropic effects of statins: evidence against benefits beyond LDL-cholesterol lowering. Pedersen TR Am J Cardiovasc Drugs; 2010; 10 Suppl 1():10-7. PubMed ID: 21391729 [TBL] [Abstract][Full Text] [Related]
4. The pleiotropic effects of statins. Calabrò P; Yeh ET Curr Opin Cardiol; 2005 Nov; 20(6):541-6. PubMed ID: 16234628 [TBL] [Abstract][Full Text] [Related]
5. Pleiotropic effects of statins: do they matter? Gotto AM; Farmer JA Curr Opin Lipidol; 2001 Aug; 12(4):391-4. PubMed ID: 11507323 [TBL] [Abstract][Full Text] [Related]
6. Statins and cardiovascular diseases: from cholesterol lowering to pleiotropy. Zhou Q; Liao JK Curr Pharm Des; 2009; 15(5):467-78. PubMed ID: 19199975 [TBL] [Abstract][Full Text] [Related]
7. Endothelial dysfunction, oxidative stress and inflammation in atherosclerosis: beneficial effects of statins. Lahera V; Goicoechea M; de Vinuesa SG; Miana M; de las Heras N; Cachofeiro V; Luño J Curr Med Chem; 2007; 14(2):243-8. PubMed ID: 17266583 [TBL] [Abstract][Full Text] [Related]
8. Pleiotropic effects of statins: evidence for benefits beyond LDL-cholesterol lowering. Marzilli M Am J Cardiovasc Drugs; 2010; 10 Suppl 1():3-9. PubMed ID: 21391728 [TBL] [Abstract][Full Text] [Related]
10. Pleiotropic effects of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors. Takemoto M; Liao JK Arterioscler Thromb Vasc Biol; 2001 Nov; 21(11):1712-9. PubMed ID: 11701455 [TBL] [Abstract][Full Text] [Related]
11. Effects of statins on 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibition beyond low-density lipoprotein cholesterol. Liao JK Am J Cardiol; 2005 Sep; 96(5A):24F-33F. PubMed ID: 16126020 [TBL] [Abstract][Full Text] [Related]
12. Beyond lipid lowering: the role of statins in vascular protection. Liao JK Int J Cardiol; 2002 Nov; 86(1):5-18. PubMed ID: 12243846 [TBL] [Abstract][Full Text] [Related]
13. Pleiotropic effects of statins. Liao JK; Laufs U Annu Rev Pharmacol Toxicol; 2005; 45():89-118. PubMed ID: 15822172 [TBL] [Abstract][Full Text] [Related]
14. Statins and cardioprotection--more than just lipid lowering? Ludman A; Venugopal V; Yellon DM; Hausenloy DJ Pharmacol Ther; 2009 Apr; 122(1):30-43. PubMed ID: 19318042 [TBL] [Abstract][Full Text] [Related]
15. Clinically relevant pleiotropic effects of statins: drug properties or effects of profound cholesterol reduction? Comparato C; Altana C; Bellosta S; Baetta R; Paoletti R; Corsini A Nutr Metab Cardiovasc Dis; 2001 Oct; 11(5):328-43. PubMed ID: 11887430 [TBL] [Abstract][Full Text] [Related]
16. Direct vascular effects of HMG-CoA reductase inhibitors. Laufs U; Liao JK Trends Cardiovasc Med; 2000 May; 10(4):143-8. PubMed ID: 11239793 [TBL] [Abstract][Full Text] [Related]
17. Inflammatory markers, cholesterol and statins: pathophysiological role and clinical importance. Biasucci LM; Biasillo G; Stefanelli A Clin Chem Lab Med; 2010 Dec; 48(12):1685-91. PubMed ID: 20868311 [TBL] [Abstract][Full Text] [Related]
18. Pleiotropic effects: should statins be considered an essential component in the treatment of dyslipidemia? Mays ME; Dujovne CA Curr Atheroscler Rep; 2008 Feb; 10(1):45-52. PubMed ID: 18366985 [TBL] [Abstract][Full Text] [Related]
19. Pleiotropic effects of 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors: candidate mechanisms for anti-lipid deposition in blood vessels. Kumai T; Matsumoto N; Koitabashi Y; Takeba Y; Oonuma S; Sekine S; Tadokoro M; Kobayashi S Curr Med Chem Cardiovasc Hematol Agents; 2005 Jul; 3(3):195-201. PubMed ID: 15974884 [TBL] [Abstract][Full Text] [Related]